Tirelizumab in Combination With Chemoradiation in Patients With Unresectable Gastric Cancer or Gastroesophageal Junction Adenocarcinoma

NCT05528367 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

33

Enrollment

OTHER

Sponsor class

Conditions

Locally Advanced Gastric Cancer

Interventions

DRUG: Nab-PTX,S-1,Tirelizumab
RADIATION: Chemoradiation

Sponsor

Zhejiang Cancer Hospital